Bikanta

🗓 Founded 2013👥 4 employees💰 Last funded Aug 2014
Biotechnology🌐 bikanta.com
Website LinkedIn
Bikanta is introducing revolutionary nanodiamond-based technology to push the boundaries of current medical imaging and diagnostics, allowing researchers to answer questions and medics to detect diseases that they currently cannot. A nanodiamond is forever. They are brightly fluorescent, infinitely stable, non-toxic, functionalizable and can be used for background-free optical imaging. Early results have improved the signal by as much as 100-fold over conventional fluorescence imaging techniques. Bikanta’s vision is to redefine the boundaries of medical diagnostics by delivering cutting-edge imaging probes and background-free optical imaging.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2013
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Bikanta?
Bikanta has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Bikanta last raise funding?
The most recent investment in Bikanta recorded on gritt.io was in August 2014.
When was Bikanta founded?
Bikanta was founded in 2013.
What industry is Bikanta in?
Bikanta operates in Biotechnology. Find similar Biotechnology investors on gritt.io.